Marcela Kober

“ES UN PRIVILEGIO PODER ACCEDER AL SERVICIO DE SALUD” A nivel nacional se eliminó el Instituto del Cáncer, pero en Misiones la asistencia es plena y en breve el PET atenderá con última tecnología y 100% público, dijo Marcela Kober, directora del Instituto Misionero del Cáncer.

Link de inscripción: forms.gle/9nss1x9KxW2KrR… Auspicio institucional de la Asociación Argentina de Oncología Clínica

Te esperamos en el próximo congreso de Sarcomas y GIST 😊 Tendremos presentación de trabajos 🥳

Updated guidelines on management of pts with #desmoid tumors out in @JAMAOnc! 🆕local ablative therapies 🆕indications for surgery 🆕place of γ-secretase inhibitor nirogacestat 👏 Congrats to all authors from Desmoid Tumor Working Group jamanetwork.com/journals/jamao…

🌎🧠Each year on June 8th, #WorldBrainTumorDay is celebrated to raise awareness, educate about brain tumors, & support those affected by it. EANO is dedicated to foster advances in #NeuroOncology through innovative research, concerted education & training eano.eu

el Dr. Matías Chacón, presentó SELNET (Sarcoma European and Latin American multidisciplinary NETwork - del cual GEIS forma parte- explicó como la participación del paciente puede mejorar los resultados de salud global en el sarcoma.

Congratulations to all the authors of #Hercules trial (LACOG 0218) @fsabino_onco @SoaresAndrey @DiogoAssed and all @LACOG_group For presenting a new treatment option for #PenileCarcinoma patients 👏 #ASCO24 @ASCO

No te pierdas el webinar de mañana! "HIGHLIGHTS DE CÂNCER DE PENIS" Sábado 24 jun 2023 hrs 11:00 São Paulo Inscríbase en la fecha y horario que más le convengan: us06web.zoom.us/webinar/regist…

@Liz_ORiordan @ffolliet Thanks @Liz_ORiordan, I agree with you, giving a good talk has to go hand in hand with an appropriate presentation

@ffolliet showed me how to craft a presentation Stop using words on slides Only use a picture if it adds to the facts Trust me - (Trust Ross) - click on this link. You won't regret it ffolliet.com/2014/10/05/how… And then, I need you to do this -

The next time you go to a conference and THIS happens The speaker says something like 'This is a really busy slide' (or even worse - they don't...) I want you to PROMISE me that you will do this for me -

Chicago 2023. NSCLC Avanzado. TROPION-Lung02: Dapotomab-Deruxtecan/Pembrolizumab +/- QT Platino, demostró prometedora actividad clinica (>1L, ORR 50% Doublet, 57% Triplet). AEs: estomatitis, nauseas, anemia y fatiga. Dr Yasushi Goto

Managing the Toxicity of Estrogen Deprivation for Patients With Breast Cancer, chair @kristinrojasmd w/ @DrTLWoodard & @matteolambe 🔊 Every oncologist should hear this!! Pearls ✅Address concerns early ✅ Start moisturizers, lubricants ✅ PT, dilators 🚫 Don't fear hormones

Chicago 2023. NSCLC Avanzado KRAS G12C 1L. SCARLET Phase II Trial: Sotorasib + Carbo-Pemetrexed. ORR 89%, mPFS BIRC 5.7m, INV 7.5 m, OS pendiente.

My take on #VESPER study: 🍸ddMVAC confirms to be a very cool regimen used in referral centers (including mine). Congrats to authors! 🫙N. cycles of chemo needed to cure pts remains unknown 🍼translation in real world remains challenging 🧃Validity of conclusion slide uncertain

Chicago 2023. NSCLC Avanzado EGFR+. WU-KONG6 Pivotal Study: Sunvozertinib demostró beneficio clinico significativo en EGFR insex20 pretratados (ORR 60.8%), independiente del sitio de inserción, en pts mts SNC y progresados a Amivantamab. Perfil de seguridad tolerable. Dr Wang.

Chicago 2023. NSCLC Avanzado EGFR+. kEYNOTE-789: Sin beneficio en DFS ni OS de la adicion del Pembrolizumab al CDDP-Pemetrexed en pts progresados a TKI. Dr James Yang.

I have tweeted more than 500 times about current information in oncology. My tweet below was the most retweeted tweet in the scientific community. The topic of the tweet is the success of topical diclofenac in reducing HFS. I hope the pharmaceutical industry gets the message. What we need is easy-to-access inexpensive drugs that we can easily administer to every patient. Cancer is a serious disease, and everyone in cancer care should have the right to equitable access to the most effective treatment. Let's make an effort to decrease drug prices!!! @OncoAlert #EquitableCancerCare

Some people say “nobody wants chemo” as if they’ve found the Achilles heel of medical oncology. Right. Nobody *wants* chemo. But the truth is that many patients *need* chemo which is in very short supply. Kudos to @doctormb1 for calling attention to drug shortages at #asco23👇🏻